USA Today: Underserved autoimmune diseases demand long-term care innovation
Martha Stone, CEO of Steritas, an IQVIA Business, quoted in USA Today. To read the full article, click here.
BioTechniques: The Great Taper: steroids’ symptoms and the resultant rise of new classes of anti-inflammatories
John H. Stone MD MPH, Chair of the Steritas Scientific Advisory Board, discusses steroid-toxicity with BioTechniques. Read more
Sam Wins Two Awards in London
We are pleased to announce that Sam (Steroids and Me) has won two awards at the Data and Marketing Association 2025 Awards in the Health and Wellness and Innovation for Good categories. Sam was up ...
Sam Makes Shortlist for the DMA Awards
We are pleased to announce that Sam (Steroids and Me) has been shortlisted for the Data and Marketing Association 2025 Awards in the Health and Wellness and Innovation for Good categories. To see the ...
EBR: Opportunities in IgG4-RD for novel steroid-sparing therapeutics
John H. Stone MD MPH, Chair of the Steritas Scientific Advisory Board, discusses advances in the diagnosis and treatment of this autoimmune disorder that was classified as a unique disease in 2003. ...
Recognizing the 77th Anniversary of the First Steroid Dosing for Rheumatoid Arthritis
The 15th of September marked the beginning of Rheumatoid Arthritis Awareness Week, an event launched by the National Rheumatoid Arthritis Society (NRAS) in 2013 to educate on the symptoms and ...